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Abstract: A novel protein tyrosine phosphatase [homo-
logue of vaccinia virus _H1 phosphatase gene clone _5
(hVH-5)] was cloned ; it shared sequence similarity with
a subset of protein tyrosine phosphatases that regulate
mitogen-activated protein kinase . The catalytic region of
hVH-5 was expressed as a fusion protein and was shown
to hydrolyze p-nitrophenylphosphate and inactivate mito-
gen-activated protein kinase, thus proving that hVH-5
possessed phosphatase activity . A unique proline-rich re-
gion distinguished hVH-5 from other closely related pro-
tein tyrosine phosphatases . Another feature that distin-
guished hVH-5 from related phosphatases was that hVH-
5 was expressed predominantly in the adult brain, heart,
and skeletal muscle . In addition, in situ hybridization his-
tochemistry of mouse embryo revealed high levels of ex-
pression and a wide distribution in the central and periph-
eral nervous system . Some specific areas of abundant
hVH-5 expression included the olfactory bulb, retina, lay-
ers of the cerebral cortex, and cranial and spinal ganglia .
hVH-5 was induced in PC12 cells upon nerve growth
factor and insulin treatment in a manner characteristic of
an immediate-early gene, suggesting a possible role in
the signal transduction cascade . Key Words: Phospha-
tase-Immediate-early gene- Mitogen-activated pro-
tein kinase .
J. Neurochem. 65,1823-1833 (1995) .
A key step in the regulation of several neuronal
processes is the tyrosine phosphorylation of proteins
(Hanks et al ., 1988 ; Ullrich and Schlessinger, 1990 ;
Aaronson, 1991) . For instance, in the PC 12 cell neu-
ronal model system, nerve growth factor (NGF) has
been shown to activate a series of kinases, culminating
with differentiation ofthe cell into an electrically excit-
able sympathetic neuron-like phenotype (Greene and
Tischler, 1976 ; Dichter and Tischler, 1977 ; Gomez
and Cohen, 1991) . Cellular studies using inhibitors
indicated that protein tyrosine phosphatases (PTPases)
also play a pivotal role in this NGF-mediated response
in PC 12 cells (Gomez et al ., 1990 ; Wu and Bradshaw,
1993) . Although one PTPase has been cloned from
PC 12 cells to date (Pan et al., 1993 ; Yan et al ., 1993),
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no PTPases known to be involved in the NGF-induced
differentiation pathway have been cloned . Indeed, only
a few PTPases specific to neuronal tissues as a whole
have been characterized . These include phosphatases
that are present in the striatum (Lombroso et al .,
1991), in the olfactory epithelium (Walton et al .,
1993), and in axons of the embryonic central nervous
system in Drosophila melanogaster (Yang et al .,
1991) . The relative position of these PTPases in signal
transduction cascades and possible substrates for these
PTPases remain unidentified.
Recently, a new subset of PTPases has been de-
scribed . These PTPases dephosphorylated not only
phosphotyrosine but also phosphoserine and phos-
phothreonine, thereby broadening the scope of poten-
tial substrates that are regulated by these PTPases
(Guan et al ., 1991 ; Sun et al ., 1993 ; Ward et al ., 1994) .
These PTPases are accordingly referred to as having
dual specificity . Recent work has shown a role for
these PTPases in the cell cycle and in the mitogen-
activated protein kinase (MAPK) cascade (Millar and
Russell, 1992 ; Zheng and Guan, 1993 ; Hannon et al .,
1994 ; Ward et al ., 1994) . One member of this subclass,
the cell division cycle protein 25 (cdc25), has been
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shown to initiate cell proliferation by dephosphorylat-
ing the premitosis promoting factor complex (Millar
and Russell, 1992) . Conversely, other phosphatases
within this subclass, phosphatase of _activated _cells
(PAC-1) (Ward et al ., 1949) and homologue of _vac-
cinia virus H1 phosphatase gene clone _1 (hVH-1) (Sun
et al ., 1993 ; Zheng and Guan, 1993), appeared to in-
hibit cell proliferation by dephosphorylating and inac-
tivating MAPK, the kinase that mediates many early
cellular response cascades (Clarke, 1994; Marshall,
1994) . Transfection of hVH-1 into NIH 3T3 cells
slowed cell division and altered cell morphology into
an enlarged, multinucleated phenotype (Noguchi et al .,
1993), further supporting the conjecture that this
PTPase may function to inhibit cellular proliferation .
PAC-1 and hVH-1 have both been shown to be imme-
diate-early gene products induced by mitogenic stim-
uli, indicating that this effect on cell growth may be
articulated early in the cell response (Charles et al .,
1992 ; Rohan et al ., 1993) . hVH-1 was most abundant
in lung, although it was also found at lower levels in
many tissues including placenta, liver, pancreas, heart,
skeletal muscle, and brain (Charles et al ., 1992 ; Car-
rasco and Bravo, 1993 ; Kwak et al., 1994) . It is inter-
esting that PAC-1 was expressed predominantly in he-
matopoietic tissues, including spleen, thymus, bone
marrow, and tumor cell lines of B and T cell origin
(Rohan et al ., 1993) .
The relatively restricted distribution of the hemato-
poietic tissue-specific PTPase, PAC-l, suggested that
a similar dual-specificity PTPase may be present in
neural tissue . To identify such PTPases expressed pre-
dominantly in neuronal tissues, the genes for several
novel dual-specificity PTPases were cloned (Martell
et al ., 1994) and portions of the genes were used to
examine the tissue-specific expression of the corre-
sponding RNA by northern blot analysis . This report
describes the cloning and characterization of one of
these PTPases, hVH-5, whose expression is abundant
in brain . The deduced amino acid sequence of hVH-5
indicated that it was most similar to the dual-specificity
PTPase subset . This subset was distinguished by re-
gions of sequence similarity to cdc25 within the amino
terminus . The proline-rich carboxy terminus found in
hVH-5 is unique within the dual-specificity subclass
and this feature could be involved in the regulation of
hVH-5 function, location, or stability . In situ hybrid-
ization histochemistry of mouse embryonic day 16.5
(e16.5) tissue demonstrated that hVH-5 mRNA was
observed throughout the CNS with high levels in re-
gions of the olfactory bulb, the retina, and several lay-
ers ofthe cerebral cortex . The pattern of hVH-5 expres-
sion within the cerebral cortex suggested a trend such
that hVH-5 expression was high in differentiating (or
differentiated) neurons in developing cortex, but not
detectable in rapidly proliferating cells . hVH-5 was
also abundantly expressed in the PNS of the e16.5
mouse as indicated by intense hybridization to cranial
and spinal ganglia . In addition, hVH-5 appeared to play
J. Neurochem., Vol. 65, No. 4, 1995
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a possible role in the neurotrophic or trophic factor-
mediated response in PC 12 cells, as demonstrated by
the rapid induction of hVH-5 mRNA expression in




Unless otherwise specified, all chemicals were supplied
by Sigma Chemical Company . Radioisotopes were obtained
from Amersham Corporation . Dulbecco's modified Eagle's
medium, serum, and restriction endonucleases were pur-
chased from Bethesda Research Laboratories . Enzymatic di-
gestions with these restriction endonucleases were carried
out according to the manufacturer's instructions . T7 and T3
RNA polymerases and the RNA Transcription kit were pur-
chased from Boehringer-Mannheim Corporation and reac-
tions were carried out according to the manufacturer's speci-
fications .
Isolation of cDNA clones
Approximately one million independent recombinants of a
human fetal brain cDNA library (Stratagene) were screened
using a 1 .3-kb fragment of genomic clone hVH-4 (Martell
et al ., 1994) . This fragment was prepared by digesting hVH-
4 with Apal . The hVH-4 fragment was radiolabeled with a
multiprime labeling system (Amersham Corporation) and
[a-3ZP]dCTP (3,000 Ci/mmol) to a specific activity of 1 .5
X 109 cpm/,ug of DNA. Procedures for screening the library
were described previously (Martell et al ., 1991) . Twelve
hybridization-positive clones were obtained in duplicate .
Four of these cDNA clones were identical to the genomic
sequence hVH-4 . The remaining clones were overlapping
fragments that all corresponded to a cDNA clone (hVH-5)
that had 93% nucleotide identity to hVH-4 . The full-length
hVH-5 clone was produced by subcloning the two longest
overlapping clones into the EcoRl site of pBluescript 11
(Stratagene) to make the construct pBSctot. Sequencing was
carried out using a Sequenase kit (United States Biochemi-
cal) or using the Ladderman kit (Takara) for G/C-rich re-
gions .
A partial fragment of the mouse homologue of hVH-5
was cloned from an e16 .5 mouse library (Stratagene) . Ap-
proximately two million independent recombinants were
screened as described above and 30 clones were obtained .
Pstl digestion of one of the clones released a 500-bp frag-
ment of the mouse homologue of hVH-5 . Sequencing of this
fragment revealed that it contained the catalytic domain of
the phosphatase . This fragment was subcloned into the Pstl
site of pBluescript 11 (Stratagene) to create pMSE5P.
Protein expression and activity analysis
The enzymatic activity of the mouse homologue of hVH-
5 was assessed by expression of the cDNA as a glutathione
S-transferase (GST) fusion protein . The entire 500-bp Pstl
fragment of mouse hVH-5 was chosen for the protein expres-
sion experiments because this fragment corresponded closely
to the region of a related phosphatase, PAC-1, that was
successfully expressed as a truncated phosphatase (Ward
et al ., 1994) . The 500-bp Pstl fragment (from pMSE5P,
described above) was subcloned in frame into pGEX-KG
(Guan and Dixon, 1991) and production ofthe fusion protein
was performed as described (Guan and Dixon, 1991) . p-
Nitrophenylphosphate (pNPP) and MAPK activity assays
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were carried out as described (Zheng and Guan, 1993) ex-
cept that assay incubations were carried out for 90 min .
Activated MAPK was a generous gift of Dr. K. L. Guan,
University of Michigan, Ann Arbor, MI, U.S.A. Inhibition
studies included the PTPase inhibitor sodium orthovanadate
(Vn) at a final concentration of 2 mM, as described pre-
viously (Zheng and Guan, 1993) .
Human tissue northern blot analysis
The human multitissue northern blot and the human brain
region-specific northern blot were both purchased from
Clontech . Each lane contained 1 Mg of poly (A) + mRNA
of the various tissues or brain regions shown in each lane .
The blots were prehybridized for 2 h in 5% sodium dodecyl
sulfate, 320 mM Na2HP04 , 80 mMNaH2PO4 , pH 7.3, 1 mM
EDTA, 1 mg/ml bovine serum albumin, and 50% formamide
(Bethesda Research Laboratories) . Blots were then hybrid-
ized overnight in the same solution at 70°C with an antisense
riboprobe . The antisense riboprobe was prepared by first
linearizing pBSctot template (construct described under Iso-
lation of cDNA clones) with BamHl . The riboprobe was
labeled to a specific activity of 1 X 10 6 cpm/pg with the
linearized template, T3 RNA polymerase, [a-32p]UTP
(3,000 Ci/mmol), and the RNA Transcription kit . The blots
were washed and exposed as described by Martell et al .
(1991) .
In situ hybridization histochemistry
Mouse embryos (e16.5) were frozen in 2-methylbutane
and stored at -80°C. The embryos were sectioned (15-pm
sections) and processed for in situ hybridization histochem-
istry as described previously (Herman et al ., 1989), except
that deproteination was performed batchwise in 100 mM
Tris-HCl, pH 8.0, 50 mM containing 0.5 mg/ml proteinase
K for 5 min at 37°C . The plasmid pMSE5P, described under
Isolation of cDNA clones, was linearized with BamHI for
preparation of antisense cRNA . Alternatively, for prepara-
tion of sense cRNA, template pMSE5P was linearized with
HindIII . Antisense and sense riboprobes were produced from
the appropriate template with T3 or T7 RNA polymerase,
respectively, using the RNA Transcription kit and 35S-UTP
(3,000 Ci/mmol) . Probe was diluted in hybridization buffer
described previously (Herman et al ., 1989) to yield
2,000,000 dpm/35 p1 of buffer and incubated at 54°C for
16-20 h . Sections were rinsed as described (Herman et al .,
1989) prior to batchwise digestion with RNase A (200 ug/
ml) (Boehringer-Mannheim Corporation) in 10 mM Tris-
HCI, pH 8.0, and 0.5 M NaCl at 37°C for 60 min . Washing
and dehydration were performed as described (Herman et
al ., 1989) . Sections were exposed to Kodak XAR-5 x-ray
film (International Biotechnologies Incorporated) for 24 h
and then emulsion dipped in Kodak NTB2 nuclear emulsion
(International Biotechnologies Incorporated) for 2-3 weeks
of exposure .
PC12 cell culture and northern blot analysis
PC12 cells were grown in Dulbecco's modified Eagle's
medium with 10% horse serum and 5% fetal calf serum in
a humidified 8% CO2 incubator . Cells were treated with
NGF (100 ng/ml) or insulin (100 nM) (Bethesda Research
Laboratories) for the time periods indicated . RNA extraction
was carried out as described previously (Martell et al ., 1992)
and northern blotting was carried out using techniques de-
scribed (Maniatis et al ., 1982) . Each lane contained approxi-
mately 8 yg of poly (A) + mRNA. Hybridization conditions
were the same as described above under Human tissue north-
ern blot analysis . The riboprobe was labeled to a specific
activity of 1 X 10 6 cpm/[Lg and was prepared as described
for the in situ hybridization histochemistry experiments, ex-
cept that [a-32P] UTP (3,000 Ci/mmol) was used . The blots
were washed and exposed as described (Martell et al ., 1991) .
RESULTS
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Molecular cloning and sequence analysis
of hVH-5
To search for a variety of tissue-specific, dual-speci-
ficity PTPases, a human genomic library was screened
under various stringencies using a partial fragment of
hVH-1 cDNA (Martell et al ., 1994) . A genomic li-
brary was chosen because many previously cloned
dual-specificity PTPases are immediate-early gene
products and therefore may be expressed only tran-
siently and not present in a cDNA library . The genes
for multiple novel dual-specificity PTPases were iden-
tified using this strategy and mapped to their respective
chromosomes (Martell et al ., 1994) . The gene reported
as hVH-4 was determined to be a pseudogene (authors'
unpublished observations), but hybridization of a
northern blot with a fragment of hVH-4 suggested the
presence of a similar PTPase that was expressed abun-
dantly in brain (data not shown) .
To isolate the cDNA encoding this PTPase, a human
fetal brain cDNA library was screened . The 2.5-kb
cDNA encoded a protein with an open reading frame
of 625 amino acids (Fig. I ) ; the putative initiator,
methionine, was identified by sequence comparison to
the optimal sequence as defined by Kozak (1981,
1984) . The presence of adenine or guanine at position
-3 and a guanine at position +4, the most invariant
aspects of the Kozak consensus sequence, was ob-
served in the context of the putative initiator methio-
nine . The position of this methionine relative to the
catalytic domain was similar to two other dual-speci-
ficity PTPases, PAC-1 and hVH-1 (Keyse and Emslie,
1992 ; Rohan et al ., 1993) . The clone was named hVH-
5 to group it systematically with related phosphatases
(Martell et al ., 1994) . Consensus sequences for mRNA
destabilization, AUUUA (Shaw and Kamen, 1986),
were observed in the 3' untranslated region of hVH-
5 (Fig . 1) . No polyadenylation sequence or poly(A)
tail was observed in the human hVH-5 clone. However,
a poly (A) tail was found in the mouse homologue of
hVH-5, just 3' to the end of the human cDNA (data
not shown) . Examination of the deduced amino acid
sequence of hVH-5 revealed multiple putative recogni-
tion sequences for protein kinases . These included pro-
tein kinase A (PKA), protein kinase C (PKC), and
the proline-directed family of kinases, specifically
MAPK and the cell cycle regulatory kinase, cell division
cycle protein 2 (cdc2) (Fig . 1) .
The encoded hVH-5 protein had the signature se-
quence (V/I)HCxAGxxR(S/T) (amino acids 244-
253) found in all protein tyrosine phosphatases (Fi-
scher et al ., 1991) . Alignment of the deduced amino
J. Neurochem., Vol . 65, No . 4, 1995
1826
	
K. J. MARTELL ET AL.
FIG . 1 . Nucleotide and deduced amino acid sequence of hVH-5 . Nucleotides are numbered above the sequence beginning at the first
nucleotide of the isolated cDNA, and amino acids are numbered at the right beginning with the putative initiator Met . The amino acid
residues that comprise the conserved catalytic PTPase domain are highlighted with an open box. The two domains that are conserved
with cdc25 (CH2 domains) are shaded . A putative phosphorylation site for PKA, RRPS (amino acids 279-282), is indicated by a solid
black dot, and the recognition sequence for PKC phosphorylation, RTLK (amino acids 298-301), is indicated by an asterisk . Putative
phosphorylation sites for proline-directed kinases are underlined . These included consensus phosphorylation sites for MAPK (Clark-
Lewis et al ., 1991), such as PGTP (residues 310-313 and 315-318), whereas SPAH (467-480) and TPRH (483-486) conformed to
the recognition site for phosphorylation by cdc2 (Moreno and Nurse, 1990) . Consensus sequences for mRNA destabilization (ATTTA)
(Shaw and Kamen, 1986) are double underlined . All proline residues are encircled .
J. Neurochem., Vol. 65, No . 4, 1995
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FIG. 2. Alignment and schematic representation of conserved
domains of hVH-5 with dual specificity PTPases. Schematic is
drawn to scale . Amino acid positions of the conserved domains
are indicated in parentheses at the beginning and end of the
sequence and a consensus line is given beneath each alignment.
Conserved amino acid residues are highlighted . A: Alignment of
the conserved active site sequence . B and C: Alignments of
the first and second CH2 domains, respectively . D: Schematic
representation of hVH-5, hVH-1, PAC-1, and human cdc25,
aligned with respect to the first CH2 domain (B) . The bands
labeled A, B, and C on the schematic correspond to the align-
ments above. The hatched box in hVH-5 represents the proline-
rich domain .
acid sequence of hVH-5 with other protein sequences
in the Genbank database demonstrated that hVH-5 was
most similar to dual-specificity PTPases . In Fig . 2A,
the catalytic domain of hVH-5 was aligned with sev-
eral closely related dual-specificity PTPases . Overall,
hVH-5 shared the greatest amino acid identity with
PAC-1 (36% amino acid identity) (Rohan et al., 1993)
and hVH-1 (34% amino acid identity) (Keyse and
Emslie, 1992) . Other related PTPases included vac-
cinia virus phosphatase H1 gene (VH1) (Guan et al .,
1991) ; yeast-related VH1 (YVH1), a PTPase induced
in yeast during nitrogen starvation (Guan et al ., 1992) ;
182 7
VH1-related phosphatase (VHR), a human fibroblast
PTPase (Ishibashi et al ., 1992) ; and cyclin-dependent
kinase-associated phosphatase (KAP), a PTPase that
interacts with cyclin-dependent kinases (Hannon et al .,
1994) . Other related dual-specificity PTPases included
the mitotic inducers, human cdc25 (Sadhu et al .,
1990), and the Drosophila homologue of cdc25, string
(Edgar and O'Farrell, 1989) . Inspection ofthe residues
surrounding the active site of the aligned PTPases re-
vealed an area of extended homology C terminal to
the signature PTPase catalytic domain. This additional
area of homology extended the signature sequence of
the active site for a subset of dual-specificity PTPases
to VxVHCxAGxSRSxTxxxAYLM (Fig . 2A) .
Further examination of the amino acid sequence re-
vealed two motifs conserved within a different subset
of the dual-specificity PTPases . These motifs in hVH-
5 were underlined in Fig . 1 and aligned with similar
regions of the homologous PTPases in Fig . 2B and C .
These two regions have been referred to as cdc25
_homology domains _2 (CH2 domains) (Keyse and
Ginsburg, 1993 ; Kwak et al ., 1994) . The location of
the CH2 domains (B and C) relative to the catalytic
domain (A) is shown schematically for hVH-5, PAC-
1, hVH-1, and cdc25 in Fig . 2D . While the CH2 do-
mains of hVH-5, PAC-1, and hVH-1 were amino ter-
minal to the catalytic domain, the CH2 domains of
cdc25 surrounded the catalytic domain . These CH2
domains were also observed in other novel PTPases
found in the genomic library screen (Martell et al .,
1994) .
One of the most distinctive features of the hVH-5
protein was the abundance of proline residues, predom-
inantly in the carboxy terminus, accounting for 12%
of the total amino acids . This proline-rich segment was
not similar to any sequences in the Genbank database .
Proline-rich segments have been examined recently as
src homology domain 3 (SH3) binding sites (reviewed
in Morton and Campbell, 1994) ; however, hVH-5 did
not interact with any SH3 domains tested (data not
shown) .
Another possible role for the proline-rich domain
may be protein stabilization . An abundance of proline
(P), glutamate (E), serine (S), and threonine (T) resi-
dues was commonly found in the most rapidly de-
graded eukaryotic proteins . Such a concentration col-
lection of these residues (in no specific order) is re-
ferred to by the acronym PEST, although aspartic acid
(D) is also manifold . The half-life of proteins con-
taining PEST sequences is frequently 1 h or less (Rog-
ers et al ., 1986) . The carboxy terminus of hVH-5 con-
tains numerous proline (17%), glutamate (6%), serine
(9%), threonine (3%), and aspartate (4%) residues,
which may serve as a PEST sequence to limit the
half-life of the protein in the cell . The putative PEST
regions, the amino acid locations of these regions, and
the associated PEST score are shown in Table 1 . The
PEST scores were graded such that the higher the
value, the greater the likelihood that the region was a
J. Neurochem., Vol . 65, No . 4, 1995
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TABLE 1 . PEST sequences of hVH-5
The PESTsequences and scores were determined accordingto aPESTFIND
program kindly provided by Dr. M. Rechsteiner, University of Utah. The
locations of the PEST sequences are indicated by the amino acid numbers
corresponding to the sequence of hVH-5 shown in Fig. 1 . Generally, the
higher the PEST score, the greater the likelihood that the region is a PEST
sequence . For comparison, the PEST scores of sequences within rapidly de-
graded proteins range from 0.1 for p53 to 24.4 for myc (Rogers et al., 1986).
PEST region . The values calculated for the PEST
scores indicated that the proline-rich regions of hVH-
5 were likely to be PEST sequences . PEST sequences
have been identified in only two other PTPases : PEP
(Matthews et al ., 1992) and PTP-PEST (Yang et al .,
1993) . Protein half-lives were not reported for PEP
and PTP-PEST ; however, the calculated PEST scores
ranged from 4.43 to 13.34 for PEP and from 2.74 to
5.27 for PTP-PEST .
A portion of mouse hVH-5 was cloned in addition
to the human sequence . The mouse clone was 88%
identical at the nucleotide level and 97% identical in
amino acid sequence compared with the corresponding
area of the human sequence (amino acid residues 134-
306) (data not shown) . The amino acid differences
between the mouse and the human clone were threo-
nine (mouse) for alanine (human) at position 143 on
the human clone ; proline for leucine at 145 ; serine for
proline at 146 ; isoleucine for valine at 211 ; and serine
for threonine at 299 . These amino acid substitutions
were not within the extended signature sequence of
the active site, indicating that this particular area is
highly conserved between species .
Phosphatase activity determination
Enzymatic activity was assessed by expressing a
portion of hVH-5 as a GST fusion protein . Successful
production of the fusion protein was achieved by ex-
pression of a truncated phosphatase corresponding to
amino acid residues 134-306 . This truncation elimi-
nated the putative PEST sequence, as well as a portion
of the amino terminus, which had interfered with ex-
pression in bacterial systems (authors' unpublished ob-
servations) . A similar truncation scheme was used suc-
cessfully by other laboratories to express PAC-1
(Ward et al ., 1994) .
hVH-5 was able to hydrolyze the artificial substrate
pNPP (Fig . 3A), which is used extensively as an indi-
cator ofphosphatase activity (Fischer et al ., 1991) . Vn,
which has been shown to be an inhibitor of PTPases
(Fischer et al ., 1991), abolished the ability of hVH-5
to hydrolyze pNPP (Fig . 3A) . GST protein alone was
unable to hydrolyze pNPP over the time period of the
assay (data not shown) .
Phosphatases that are most similar to hVH-5 have
J. Neurochem., Vod. 65, No . 4, 1995
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been shown to inactivate MAPK by dephosphorylation
on tyrosine and threonine residues (Zheng and Guan,
1993 ; Ward et al ., 1994) . MAPK activity was therefore
assayed after incubation in the presence of increasing
quantities of hVH-5. The addition of hVH-5 abolished
MAPK activity in a concentration-dependent fashion
(Fig . 3B) . Addition of Vn inhibited the ability of hVH-
5 to inactivate MAPK (data not shown) .
Tissue and brain region distribution
The specific expression pattern of hVH-5 mRNA in
human tissues was examined by northern analysis .
hVH-5 mRNA was highly abundant in brain, although
it was also present in heart and skeletal muscle (Fig .
4A) . It is noteworthy that these tissues share the com-
mon feature of being electrically excitable and able to
propagate an action potential . However, analysis of
mouse tissue mRNA indicated that hVH-5 was also
present in lung (data not shown) .
Two transcript sizes of 5.5 and 2.5 kb were observed
(Fig . 4A) . The message of approximately 5 .5 kb was
more abundant than the message at 2.5 kb, except in
the case of skeletal muscle, where the two messages
FIG. 3. Investigation of recombinant GST-hVH-5 enzymatic ac-
tivity. A: Hydrolysis of pNPP in the presence (0) or absence (" )
of 2.5 mM Vn . B: Inactivation of MAPK . Activated MAPK (0 .1
lug) was used in each point. Each point on the graph indicates
a mean of triplicate experiments and error bars indicate the SEM.
The amount of hVH-5 added to each assay is indicated as micro-
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FIG. 4. Northern blots displaying tissue and brain region expres-
sion of hVH-5. A: Tissue distribution of hVH-5 mRNA . B: Brain
region distribution of hVH-5. The migration of RNAsize markers
is shown to the left .
appeared to be expressed equivalently . The size of the
smaller message was consistent with the size of the
cDNA clone reported in Fig . 1 . The larger message
has to date resisted further cloning attempts .
Because hVH-5 is very abundant in human brain,
northern blot analysis was used to determine whether
the message was confined to a particular brain region,
or expressed ubiquitously in the CNS (Fig . 4B) . hVH-
5 message was highly expressed in all human brain
regions shown, including amygdala, caudate nucleus,
corpus callosum, hippocampus, hypothalamus, sub-
stantia nigra, subthalamic nucleus, and thalamus . As
was noted in heart and skeletal muscle (Fig . 4A), two
mRNAs of 5 .5 and 2.5 kb were observed, and again,
the message of approximately 5 .5 kb was more abun-
dant than the message at 2.5 kb .
In situ hybridization analysis
Northern analysis revealed the expression pattern
of hVH-5 in adult tissues and brain-specific regions .
However, the hVH-5 cDNA had been cloned from a
fetal human brain library . To examine the expression
of hVH-5 at a single time in embryonic development,
we examined the distribution pattern of hVH-5 mRNA
with the mouse homologue of hVH-5 in sagittal and
parasagittal sections from e16.5 mouse using in situ
hybridization histochemistry . This time point was cho-
sen because it was the same time in development as
the cDNA library source used for cloning embryonic
mouse hVH-5 .
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An autoradiograph of two adjacent sections hybrid-
ized to antisense (Fig . 5A) and sense (Fig . 5B) probes
revealed that hVH-5 was abundantly expressed in the
developing neural system . In this sagittal section of
e16.5 mouse, hVH-5 was readily observed in the devel-
oping brain, spinal cord, and cranial and spinal ganglia .
No specific signal was detected in sections hybridized
with sense cRNA probe, demonstrating the specificity
of hybridization . Photomicrographs of emulsion-dipped
sections further refined the examination of hVH-5 ex-
pression in the CNS and PNS (Figs. 6 and 7) . hVH-5
mRNA was observed in almost all regions of the e16.5
brain, including developing cerebral cortex, forebrain,
diencephalon (hypothalamus and thalamus), midbrain,
pons, medulla, and cerebellar primordium (Fig . 6A) .
Expression levels appeared similar throughout most re-
gions of the developing mouse brain, with the exception
of very high levels in the olfactory bulb (Fig . 6B) .
Levels of hVH-5 expression also appeared to vary
across the layers of developing cerebral cortex (Fig .
6C) . The rapidly proliferating neuroepithelial cells at
the ventricular zone showed very little hVH-5 expres-
FIG. 5. In situ hybridization analysis of hVH-5 mRNA in mouse.
Sagittal sections of mouseembryos (e16 .5) were hybridized to
antisense and sense 35 S-labeled hVH-5 riboprobes . A: Autora-
diogram of a sagittal section hybridized to antisense hVH-5
cRNA probe. B: Autoradiogram of the adjacent sagittal section
hybridized to sense hVH-5 cRNA.
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FIG. 6. Expression of hVH-5 mRNA in brain of e16.5 mouse embryo . Dark-field photomicrographs of sagittal sections hybridized with
35 S-labeled antisense hVH-5 cRNA probe are shown. A: Developing mouse brain. B: Olfactory bulb . C: Developing cerebral cortex .
Locations are as follows: OB, olfactory bulb ; Hy, hypothalamus ; T, thalamus ; 3V, third ventricle ; MB, midbrain ; P, pons ; M, medulla;
CbP, cerebellar primordia; 4V, fourth ventricle ; TG, trigeminal ganglion ; VZ, ventricular zone ; IZ, immediate zone ; CP, cortical plate;
MZ, marginal zone. Magnification bars represent 200 ym (A), 200 ym (B), and 100 pm (C) .
sion, whereas the intermediate zone and marginal zone
showed much higher levels of expression .
hVH-5 expression was also observed in the e16.5
mouse retina and olfactory epithelium, both compo-
nents of the CNS. The results suggested that high levels
of hVH-5 mRNA were distributed in differentiating
(or differentiated) ganglion cells of the retina, although
this region could include developing amacrine, bipolar,
or Mueller cells (Fig. 7A) . Cells in the outer nuclear
layer of the retina showed very little hVH-5 expression .
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Low levels of hVH-5 mRNA were also seen in the
olfactory epithelium (data not shown) . In addition, the
spinal cord exhibited high levels of hVH-5 expression
(Fig . 7B) .
Within the e16.5 mouse PNS, hVH-5 mRNA was
readily observed in the cranial ganglia and spinal gan-
glia . High levels of expression were observed in the
trigeminal (Fig . 6A), facial, and glossopharyngeal
ganglia. The dorsal root ganglia (Fig . 7C) also exhib-
ited high levels of hVH-5 mRNA.
hVH-5: A NOVEL PROTEIN TYROSINE PHOSPHATASE
FIG. 7. Expression of hVH-5 mRNA in developing CNSandPNS.
Dark-field photomicrographs of sagittal sections hybridized with
35 S-labeled antisense hVH-5 cRNA probe are shown. A: hVH-5
mRNA was highly expressed in differentiating (or differentiated)
cells in the proximity of the developing ganglion cell layer. B:
High levels of hVH-5 mRNA were observed in the spinal cord .
C: The dorsal root ganglia exhibited high levels of hVH-5 mRNA.
Locations are as follows: GCL, putative ganglion cell layer; ONL,
outer nuclear layer; HC, hyaloid cavity ; V, cartilage primordium
of vertebra; cc, central canal of spinal cord . Magnification bars
correspond to 50 pm (A), 200 pm (B), and 200 pm (C).
Expression in differentiating PC12 cells
PAC-1 and hVH-l, the PTPases that were the most
similar to hVH-5, have been shown to be immediate-
early gene products that inactivate MAPK and may
act as negative regulators of cell proliferation . It was
therefore of interest to determine whether hVH-5 was
also an immediate-early gene product, thereby sug-
gesting that hVH-5 may perform a function similar to
DISCUSSION
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PAC-1 and hVH-1 . A number of cultured cell lines
were examined for hVH-5 expression by northern blot
analysis . Transcripts were observed in the human neu-
roblastoma cell lines SY5Y and Lan-5, and in rat pheo-
chromocytoma PC 12 cells (data not shown) . PC12
cells were chosen as a model system because stimula-
tion of these cells by the neurotrophin NGF or the
trophic factor insulin triggers the MAPK pathway
(Dikic et al ., 1994) . Accordingly, the early time course
of hVH-5 expression was examined in NGF- and insu-
lin-treated PC 12 cells .
hVH-5 mRNA levels increased within 30 min to a
maximum induction in PC 12 cells stimulated by NGF
or insulin (Fig . 8) . This elevation was sustained at the
1-h time point, and was reduced to pretreatment levels
by 3 h . mRNA levels increased again by 12 h posttreat-
ment . The intensity of the signals on both blots was
normalized to the abundance of cyclophilin, which was
used as a control to account for variability in mRNA
quantity between lanes and experiments (data not
shown) . Replicate experiments indicated a similar
magnitude and time course of hVH-5 induction in
PC12 cells treated with NGF or insulin (data not
shown) . These results mimicked the early time course
of PAC-1 and hVH-1 induction (Charles et al ., 1992 ;
Rohan et al ., 1993) and indicated that hVH-5 is an
immediate-early gene product, which is also induced
at later time points . This result was consistent with
possible involvement of hVH-5 in inactivation of the
MAPK cascade in PC12 cells .
hVH-5 is a novel immediate-early gene product that
was abundant in brain and had amino acid identity with
the dual-specific subfamily of PTPases . Comparison of
the primary sequence of hVH-5 with related PTPases
revealed an extended active site region : VxVHCxAGx-
SRSxTxxxAYLM that appeared to be a hallmark for
a subset of dual-specificity PTPases (hVH-5, hVH-
1, PAC-1, VHR, VH1, YVH1) . Additional areas of
homology included the CH2 domains, which may play
a role in defining substrate specificity or serve as a
recruiting site for other proteins (Keyse and Ginsburg,
1993) . The presence of the CH2 domains may also
serve to define a restricted subset of the dual-specificity
PTPases, because it was not present in other dual-
specificity PTPases including VHR, VH1, YVH1,
and KAP.
FIG. 8. Expression of hVH-5 and mRNA in PC12 cells after incu-
bation with NGF or insulin for 0, 0.5, 1, 3, 6, or 12 h.
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The presence of a proline-rich carboxyl extension in
hVH-5 was unique among the dual-specificity PTPase
subclass . The proline-rich tail may function as a regula-
tory domain for the abundance of hVH-5 protein if the
putative PEST regions within hVH-5 are utilized as
signals for rapid degradation within the cell . If this is
the case, then the temporal abundance of hVH-5 may
be regulated at multiple levels within the cell : hVH-5
may be controlled through PEST sequences at the pro-
tein level, and hVH-5 mRNA levels may be regulated
through the presence of mRNA destabilization signals
within the 3' untranslated region (Fig . 1) . The mRNA
destabilization signal is commonly found in the
mRNAs of transiently expressed genes and is proposed
to be a signal sequence for mRNA degradation in cer-
tain immediate-early gene products (Shaw and Kamen,
1986) . The identification of hVH-5 as an immediate-
early gene product is consistent with the possibility
that these sequences are indeed mRNA destabilization
signals. These destabilization sequences were also
found in the 3' untranslated regions of the related dual-
specificity PTPases, PAC-1 and hVH-1 (Keyse and
Emslie, 1992; Rohan et al ., 1993) . The presence of
translational and transcriptional regulatory sequences
suggests that hVH-5 mRNA expression may be tightly
controlled and the encoded protein rapidly degraded .
It is also noteworthy, as hVH-5 was so abundant in
brain, that extended proline-rich regions have been ob-
served in synaptic vesicle-associated proteins (Trimble
and Scheller, 1988) .
In the mouse embryo, hVH-5 was abundant through-
out the CNS and PNS (Figs . 5-7) . The ubiquitous
and abundant nature of hVH-5 expression in the em-
bryo brain was similar to the high levels of expression
of hVH-5 mRNA observed throughout the adult human
brain by northern blot analysis (Fig . 4B) . Although
hVH-5 appeared to be abundant in differentiating (or
differentiated) neural cells in the embryo as well as in
differentiated neural tissue in the adult, a complete
developmental analysis will be necessary to draw con-
clusions about the nature of hVH-5 expression in neu-
rogenesis . Such studies are currently underway in our
laboratory with hVH-5, and other investigators have
already reported such developmental studies for exter-
nally regulated phosphatase, another dual-specificity
PTPase (Carrasco and Bravo, 1993) .
In situ hybridization histochemistry studies with the
proline-directed cyclin-dependent kinase 5 (cdk5), a
homologue of the cell cycle kinase cdc2, indicated
that cdk5 was abundant in regions similar to hVH-5,
including brain, spinal cord, and ganglia (Hellmich et
al ., 1992 ; Tsai et al., 1993) . Several phosphorylation
sites for proline-directed kinases were observed within
the amino acid sequence of hVH-5 (Fig . 1) and, con-
ceivably, the activity of hVH-5 could be modified by
any of these kinases . In addition, KAP, another dual-
specificity PTPase with sequence similarity to hVH-5,
interacts with cyclin-dependent kinases, including cdc2
(Hannon et al ., 1994) . Taken together, these data sug-
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gest that hVH-5 and cdk5 could interact with one an-
other, and it would be of interest to explore a potential
relationship between these two enzymes .
In PC12 cells, hVH-5 was induced by the neuro-
trophic factor NGF, and by the trophic factor insulin .
Recent evidence suggests that in PC12 cells NGF and
insulin mediate differentiation and proliferation, re-
spectively, through common signaling mechanisms
that involve the activation of MAPK. The differences
in the cellular endpoints were thought to reside in dif-
ferences in the magnitude and duration of MAPK acti-
vation and differences in the subcellular localization
of MAPK (Dikic et al ., 1994 ; Traverse et al ., 1994) .
The factors that act to direct these differences in
MAPK are poorly understood ; however, it is possible
that proteins such as hVH-5 could influence the activa-
tion of MAPK or other key regulatory proteins, and
thus play a pivotal role in the determination of prolifer-
ation or differentiation . The ability of hVH-5 to inacti-
vate MAPK in vitro is consistent with such a role for
hVH-5 . Extended examination of hVH-5 in PC 12 cells
may yield key observations about its function.
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